HOME >> MEDICINE >> NEWS
Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix

Aspirin dose and type may not matter when taken in combination with Plavix for the purpose of thinning blood and possibly reducing the risk of stroke in people with cerebrovascular disease, according to research presented today at the American Stroke Association's 29th International Stroke Conference. The American Stroke Association is a division of the American Heart Association.

Northwestern Memorial researchers previously reported that the majority of patients who took baby or enteric-coated aspirin alone to prevent strokes were not getting the desired blood-thinning effects, causing concern among patients who chose to take coated or baby aspirin because of their reduced risk of gastrointestinal side effects.

"That's why we decided to study the efficacy of aspirin - in various doses and formulations - when taken in combination with Plavix," explains Mark J. Alberts, M.D., director of the stroke program at Northwestern Memorial Hospital and the study's lead author. "Plavix is a prescription antiplatelet medication that helps keep platelets in the blood from sticking together and forming clots. Plavix has fewer gastrointestinal side effects than adult-dose aspirin."

"While research has shown that the combined use of aspirin and Plavix provides an enhanced blood-thinning effect for patients trying to reduce their risk of vascular events, the optimal dose and formulation is unclear," according to Dr. Alberts. "This study is significant in that it continues to point researchers in the right direction - showing how we can maximize the effectiveness and safety of aspirin when used to reduce the risk of stroke."

Northwestern Memorial investigators collected data on aspirin dose, type (coated or uncoated), and demographic factors on a total of 69 in-patients and out-patients with cerebrovascular disease, including ischemic stroke and transient ischemic attacks (TIAs). Antiplatelet effects of aspirin were measured using a machine abo
'"/>

Contact: Patty Keiler
pkeiler@nmh.org
312-926-5900
Northwestern Memorial Hospital
5-Feb-2004


Page: 1 2

Related medicine news :

1. Loyola study shows drug-coated stent induces less inflammation than bare metal stent
2. Drug-coated stents effective in real world patients
3. The trojan clot-buster: Drug-coated red blood cells destroy blood clots from within
4. New study of coated stent long-term results disappointing
5. Silver-coated catheters cut infections & may save money, analysis finds
6. Many postmenopausal women with cardiovascular disease dont use lifesaving aspirin therapy
7. Survivors who stop taking aspirin increase risk of another stroke
8. Study says 43% of US adults at risk of heart disease are not utilizing aspirin therapy
9. Low-dose aspirin and stomach ulcer medications better for heart patients with GI complications
10. Statins and aspirin may protect against severe vision loss in elderly
11. One in five asthmatics are highly sensitive to aspirin

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... August 19, 2017 , ... Parker at Stonegate, ... over 1,000 passionate employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading ... it was time to refresh the carpeting with the goal of maintaining the ...
(Date:8/18/2017)... , ... ... ... For Immediate Release                Contact: ... Shows Young Women Seek Sex and Relationship Advice from their ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... liquid handling handheld devices. Through an educational webinar, they will present the line ... a chance to learn how easy you can automate everyday pipetting tasks. , ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning assistance that serves communities throughout southern Florida, is working to ... provide scholarship assets to children from low income families. , The Take Stock ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... PETACH TIKVAH, Israel , Aug. 15, ... leading developer of adult stem cell technologies for neurodegenerative ... June 30, 2017. ... our pivotal Phase 3 trial to investigate NurOwn ® ... and Chief Executive Officer of BrainStorm. "We have agreements ...
(Date:8/8/2017)... Aug. 8, 2017   ... diluted (GAAP) loss per share from continuing operations ... revenues increased 16 percent to $110 million ... 27 percent to $161 million ... from continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
Breaking Medicine Technology:
Cached News: